103
Participants
Start Date
August 12, 2019
Primary Completion Date
April 26, 2021
Study Completion Date
April 26, 2021
RPT193
Antagonist of the CCR4 chemokine receptor
Placebo
Matching placebo
Sadick Research Group LLC, New York
Lenus Research & Medical Group, Miami
ForCare Clinical Research, Tampa
Pinnacle Research Group, LLC, Anniston
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Clinical Trials Management,LLC, Metairie
DelRicht Research, Baton Rouge
Central Sooner Research, Norman
Progressive Clinical Research PA, San Antonio
DermResearch, Inc., Austin
Perseverance Research Center LLC, Scottsdale
University Clinical Trials, Inc, San Diego
MetroBoston Clinical Partners LLC, Brighton
PRA, Groningen
RAPT Therapeutics, Inc.
INDUSTRY